Table 1 Baseline characteristics of participants by Cardiometabolic diseases status at follow-up.
Total | Non-cardiometabolic diseases | Cardiometabolic diseases | P | |
|---|---|---|---|---|
6471 | 4956 | 1515 | ||
Age (median [IQR]),(years) | 55.0 [49.0, 61.0] | 55.0 [49.0, 61.0] | 57.0 [51.0, 63.0] | < 0.001 |
Female, n(%) | 3251 (50.2) | 2452 (49.5) | 799 (52.7) | 0.028 |
Middle school and low, n (%) | 6360 (98.3) | 4871 (98.3) | 1489 (98.3) | 1 |
Ever smoker, n (%) | 2610 (40.3) | 2025 (40.9) | 585 (38.6) | 0.126 |
Ever drinker, n(%) | 2386 (36.9) | 1846 (37.2) | 540 (35.6) | 0.27 |
Urban Community, n(%) | 1044 (16.1) | 822 (16.6) | 222 (14.7) | 0.08 |
Married, n(%) | 5894 (91.1) | 4544 (91.7) | 1350 (89.1) | 0.002 |
Sleep duration (median [IQR]) | 7.0 [5.0, 8.0] | 7.0 [5.0, 8.0] | 7.0 [5.0, 8.0] | 0.059 |
BMI (median [IQR]) | 23.1 [21.6, 25.0] | 23.0 [21.4, 24.7] | 23.6 [22.0, 25.9] | < 0.001 |
TyG (median [IQR]) | 8.5 [8.2, 8.9] | 8.5 [8.1, 8.9] | 8.6 [8.3, 9.0] | < 0.001 |
CHG (median [IQR]) | 5.2 [5.0, 5.5] | 5.2 [5.0, 5.5] | 5.3 [5.1, 5.6] | < 0.001 |
TC (median [IQR]),(mg/dl) | 187.9 [165.5, 211.9] | 186.0 [164.3, 210.3] | 192.1 [169.9, 215.7] | < 0.001 |
FPG (median [IQR]),(mg/dl) | 101.0 [93.4, 109.6] | 100.1 [92.9, 108.5] | 103.1 [95.6, 113.9] | < 0.001 |
TG (median [IQR]),(mg/dl) | 99.1 [72.6, 142.5] | 95.6 [70.8, 138.1] | 108.9 [77.9, 154.9] | < 0.001 |
HDL-C (median [IQR]),(mg/dl) | 51.0 [41.8, 61.5] | 51.4 [42.1, 61.5] | 49.5 [40.6, 61.1] | 0.004 |
LDL-C (median [IQR]),(mg/dl) | 112.9 [92.4, 135.3] | 112.1 [91.6, 134.5] | 116.0 [95.9, 138.6] | < 0.001 |
CRP (median [IQR]),(mg/l) | 0.9 [0.5, 1.8] | 0.8 [0.5, 1.8] | 1.0 [0.5, 2.1] | < 0.001 |
